KCT0008847
招募中
未知
Clinical usefulness of virtual antiarrhythmic drug test in patients with recurred AF after catheter ablation (CUVIA-AF3)
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Yonsei University Health System, Severance Hospital
- 入组人数
- 300
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. The patients with 20\~80 years old those recurred AF after catheter ablation
- •2\. Patients who are suitable for sinus rhythm conversion and maintenance using AAD medications
- •3\. Patients who had no history of serious side effects due to AAD medications before the procedure
排除标准
- •1\. Permanent AF Patients
- •2\. AF associated with significant structural heart disease with severe anomaly or hemodynamic effects
- •3\. Patients expected to have serious side effects when using AAD due to sinus node dysfunction
- •4\. Severe liver or renal failure
- •5\. Patients with past cardiac surgery history
- •6\. Patients who are unable to oral medication or have electrolyte abnormalities
- •7\. Patients with active internal bleeding
- •8\. Contraindications for anticoagulant therapy (administered anticoagulant drugs to prevent cerebral infarction) or AAD
- •9\. Valvular AF (mitral stenosis\> grade 2, mechanical valve, mitral valve repair)
- •10\. Severe concomitant illness
结局指标
主要结局
未指定
相似试验
招募中
不适用
Clinical Effectiveness of Atrial Anti-tachycardia Pacing Therapy in Sick Sinus Syndrome with Previous Atrial Fibrillation Ablation (CEASE-AF)Sick sinus syndromeAtrial FibrillationCardiovascular - Other cardiovascular diseasesACTRN12616001353482Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital136
尚未招募
1 期
Antiarrhythmic effects of phenytoin or dantrolene in patients with cardiomyopathy.ACTRN12619000730101niversity of Newcastle105
进行中（未招募）
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.EUCTR2009-014940-12-FRInstitut de Recherches Internationales Servier160
已完成
2 期
Evaluation of the anti-arrhythmic effects of 3 dosages of S 44121 versus placebo in patients with chronic heart failure at risk for ventricular arrhythmiaCardiac arrhythmia in chronic heart failureCirculatory SystemOther cardiac arrhythmiasISRCTN14227980Institut de Recherches Internationales Servier (France)149
进行中（未招募）
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 12.1Level: LLTClassification code 10007558Term: Cardiac failure chronicMedDRA version: 12.1Level: LLTClassification code 10049694Term: Left ventricular dysfunctionMedDRA version: 12.1Level: LLTClassification code 10047281Term: Ventricular arrhythmiaEUCTR2009-014940-12-HUInstitut de Recherches Internationales Servier160